Elon Musk’s Neuralink brain computer startup is beat again. This time a competitor implanted its device into its first U.S. patient

Synchron, the brain computer startup and Neuralink rival, is beginning its FDA approved human trial in the U.S., following a human trial in Australia. Read More

Read More?

Post is imported from RSS feed, by one of our guest editors. G6 does not edit or moderate the content. G6 is not responsible for your actions. No rights owned by G6. To remove the post, please email us at [email protected]

No Comments

Sorry, the comment form is closed at this time.